{"schema_version":"secwatch.filing_event.v1","accession":"0001453687-24-000055","form_type":"8-K","ticker":"RNAC","cik":"0001453687","company_name":"Cartesian Therapeutics, Inc.","filed_at":"2024-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.480850+00:00","generated_at":"2026-06-04T00:53:36.037368+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cartesian Therapeutics Series A Preferred automatically converts, resulting in 17.8M shares outstanding","bullets":["Automatic conversion of Series A Non-Voting Convertible Preferred Stock occurred on April 8, 2024.","After conversion, common stock outstanding totals 17,779,787 shares.","No further Series A Preferred shares remain outstanding; previously approved by stockholders on March 27, 2024.","Company also filed updated corporate slide presentation for investor conferences."],"urls":{"canonical":"https://secwatch.observer/filing/0001453687-24-000055","json":"https://secwatch.observer/filing/0001453687-24-000055.json","markdown":"https://secwatch.observer/filing/0001453687-24-000055.md","text":"https://secwatch.observer/filing/0001453687-24-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453687/000145368724000055/0001453687-24-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453687/000145368724000055/rnac-20240408.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T00:53:36.037368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}